Home › Bladder Cancer › Colorado › Lakewood
Bladder Cancer clinical trials in Lakewood, CO
4 studies for Bladder Cancer are looking for participants at sites in and around Lakewood (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- CommonSpirit Saint Anthony Hospital Cancer Center, Lakewood
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RecruitingPhase 2
- Colorado Urology, Lakewood
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RecruitingPhase 2
- Advanced Urology, Lakewood
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- Colorado Clinical Research, Lakewood
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Houston, TX31 studies
- Nashville, TN31 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Boston, MA26 studies
- Baltimore, MD24 studies
- Los Angeles, CA24 studies
- St. Louis, MO22 studies
- Seattle, WA21 studies
- Edison, NJ21 studies
- Philadelphia, PA21 studies
Other studies in Lakewood
- Prostate Cancer7 studies
- Breast Cancer5 studies
- Colon Cancer5 studies
- Colorectal Cancer5 studies
- Non-Muscle Invasive Bladder Cancer4 studies
- Macular Degeneration3 studies
- Non-Small Cell Lung Cancer3 studies
- Rectal Cancer3 studies
- Stomach Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.